GRIMALDI, Elena
GRIMALDI, Elena
Distribution of Hepatitis C Virus Genotypes and Subtypes in the Metropolitan Area of Naples, Italy, in the Era of Interferon-Free Regimens.
2017 Grimaldi, Elena; Della Pepa, Maria Elena; Martora, Francesca; Magliocca, Pasqualino; Iovene, Maria Rosaria; Coppola, Nicola; Donnarumma, Giovanna; Galdiero, Massimiliano
Efficacy and safety of tixagevimab-cilgavimab (Evusheld®) in people with Multiple Sclerosis on Ocrelizumab: preliminary evidence
2023 Altieri, Manuela; Melisi, Rosario Domenico; Conte, Miriana; Capuano, Rocco; Donnarumma, Giovanna; Grimaldi, Elena; Coppola, Nicola; De Pascalis, Stefania; Risi, Mario; D'Ambrosio, Alessandro; Bisecco, Alvino; Gallo, Antonio
Humoral response and safety of the third booster dose of BNT162b2 mRNA COVID-19 vaccine in patients with multiple sclerosis treated with ocrelizumab or fingolimod
2022 Capuano, Rocco; Altieri, Manuela; Conte, Miriana; Bisecco, Alvino; D'Ambrosio, Alessandro; Donnarumma, Giovanna; Grimaldi, Elena; Coppola, Nicola; Medici, Nicola; Galdiero, Massimiliano; Tedeschi, Gioacchino; Gallo, Antonio
Humoral response to SARS-CoV-2 mRNA vaccine in patients with multiple sclerosis treated with natalizumab
2021 Capuano, R.; Donnarumma, G.; Bisecco, A.; Grimaldi, E.; Conte, M.; D'Ambrosio, A.; Matrone, F.; Risi, M.; Borgo, R. M.; Altieri, M.; Giuliano, F.; Coppola, N.; Galdiero, M.; Tedeschi, G.; Gallo, A.
Preliminary evidence of blunted humoral response to SARS-CoV-2 mRNA vaccine in multiple sclerosis patients treated with ocrelizumab
2021 Gallo, A.; Capuano, R.; Donnarumma, G.; Bisecco, A.; Grimaldi, E.; Conte, M.; D'Ambrosio, A.; Coppola, N.; Galdiero, M.; Tedeschi, G.
Seven years prevalence and distribution of high and low risk HPV genotypes in women living in the metropolitan area of Naples
2019 Martora, F.; Della Pepa, M. E.; Grimaldi, E.; Franci, G.; Folliero, V.; Petrillo, A.; Schettino, M. T.; De Franciscis, P.; Galdiero, M.; Galdiero, M.
Six-month humoral response to BNT162b2 mRNA COVID-19 vaccine in people with multiple sclerosis treated with natalizumab
2022 Altieri, M.; Capuano, R.; Conte, M.; Donnarumma, G.; Grimaldi, E.; Coppola, N.; Galdiero, M.; D'Ambrosio, A.; Tedeschi, G.; Gallo, A.
Six-month humoral response to mRNA SARS-CoV-2 vaccination in patients with multiple sclerosis treated with ocrelizumab and fingolimod
2022 Capuano, R; Bisecco, A; Conte, M; Donnarumma, G; Altieri, M; Grimaldi, E; Franci, G; Chianese, A; Galdiero, M; Coppola, N; Tedeschi, G; Gallo, A
Tuberculosis infection screening in 5468 italian healthcare students: Investigation of a borderline zone value for the QFT-test
2020 Corvino, A. R.; Monaco, M. G. L.; Maria Garzillo, E.; Grimaldi, E.; Donnarumma, G.; Miraglia, N.; Giuseppe, G. D.; Lamberti, M.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Distribution of Hepatitis C Virus Genotypes and Subtypes in the Metropolitan Area of Naples, Italy, in the Era of Interferon-Free Regimens. | 1-gen-2017 | Grimaldi, Elena; Della Pepa, Maria Elena; Martora, Francesca; Magliocca, Pasqualino; Iovene, Maria Rosaria; Coppola, Nicola; Donnarumma, Giovanna; Galdiero, Massimiliano | |
| Efficacy and safety of tixagevimab-cilgavimab (Evusheld®) in people with Multiple Sclerosis on Ocrelizumab: preliminary evidence | 1-gen-2023 | Altieri, Manuela; Melisi, Rosario Domenico; Conte, Miriana; Capuano, Rocco; Donnarumma, Giovanna; Grimaldi, Elena; Coppola, Nicola; De Pascalis, Stefania; Risi, Mario; D'Ambrosio, Alessandro; Bisecco, Alvino; Gallo, Antonio | |
| Humoral response and safety of the third booster dose of BNT162b2 mRNA COVID-19 vaccine in patients with multiple sclerosis treated with ocrelizumab or fingolimod | 1-gen-2022 | Capuano, Rocco; Altieri, Manuela; Conte, Miriana; Bisecco, Alvino; D'Ambrosio, Alessandro; Donnarumma, Giovanna; Grimaldi, Elena; Coppola, Nicola; Medici, Nicola; Galdiero, Massimiliano; Tedeschi, Gioacchino; Gallo, Antonio | |
| Humoral response to SARS-CoV-2 mRNA vaccine in patients with multiple sclerosis treated with natalizumab | 1-gen-2021 | Capuano, R.; Donnarumma, G.; Bisecco, A.; Grimaldi, E.; Conte, M.; D'Ambrosio, A.; Matrone, F.; Risi, M.; Borgo, R. M.; Altieri, M.; Giuliano, F.; Coppola, N.; Galdiero, M.; Tedeschi, G.; Gallo, A. | |
| Preliminary evidence of blunted humoral response to SARS-CoV-2 mRNA vaccine in multiple sclerosis patients treated with ocrelizumab | 1-gen-2021 | Gallo, A.; Capuano, R.; Donnarumma, G.; Bisecco, A.; Grimaldi, E.; Conte, M.; D'Ambrosio, A.; Coppola, N.; Galdiero, M.; Tedeschi, G. | |
| Seven years prevalence and distribution of high and low risk HPV genotypes in women living in the metropolitan area of Naples | 1-gen-2019 | Martora, F.; Della Pepa, M. E.; Grimaldi, E.; Franci, G.; Folliero, V.; Petrillo, A.; Schettino, M. T.; De Franciscis, P.; Galdiero, M.; Galdiero, M. | |
| Six-month humoral response to BNT162b2 mRNA COVID-19 vaccine in people with multiple sclerosis treated with natalizumab | 1-gen-2022 | Altieri, M.; Capuano, R.; Conte, M.; Donnarumma, G.; Grimaldi, E.; Coppola, N.; Galdiero, M.; D'Ambrosio, A.; Tedeschi, G.; Gallo, A. | |
| Six-month humoral response to mRNA SARS-CoV-2 vaccination in patients with multiple sclerosis treated with ocrelizumab and fingolimod | 1-gen-2022 | Capuano, R; Bisecco, A; Conte, M; Donnarumma, G; Altieri, M; Grimaldi, E; Franci, G; Chianese, A; Galdiero, M; Coppola, N; Tedeschi, G; Gallo, A | |
| Tuberculosis infection screening in 5468 italian healthcare students: Investigation of a borderline zone value for the QFT-test | 1-gen-2020 | Corvino, A. R.; Monaco, M. G. L.; Maria Garzillo, E.; Grimaldi, E.; Donnarumma, G.; Miraglia, N.; Giuseppe, G. D.; Lamberti, M. |